301 related articles for article (PubMed ID: 20495085)
1. Genetic/familial high-risk assessment: breast and ovarian.
Daly MB; Axilbund JE; Buys S; Crawford B; Farrell CD; Friedman S; Garber JE; Goorha S; Gruber SB; Hampel H; Kaklamani V; Kohlmann W; Kurian A; Litton J; Marcom PK; Nussbaum R; Offit K; Pal T; Pasche B; Pilarski R; Reiser G; Shannon KM; Smith JR; Swisher E; Weitzel JN;
J Natl Compr Canc Netw; 2010 May; 8(5):562-94. PubMed ID: 20495085
[No Abstract] [Full Text] [Related]
2. Hereditary breast and ovarian cancer (HBOC): clinical features and counseling for BRCA1 and BRCA2, Lynch syndrome, Cowden syndrome, and Li-Fraumeni syndrome.
Shulman LP
Obstet Gynecol Clin North Am; 2010 Mar; 37(1):109-33, Table of Contents. PubMed ID: 20494261
[TBL] [Abstract][Full Text] [Related]
3. Beyond BRCA1 and BRCA2 wild-type breast and/or ovarian cancer families: germline mutations in TP53 and PTEN.
Blanco A; Graña B; Fachal L; Santamariña M; Cameselle-Teijeiro J; Ruíz-Ponte C; Carracedo A; Vega A
Clin Genet; 2010 Feb; 77(2):193-6. PubMed ID: 19930417
[No Abstract] [Full Text] [Related]
4. Genetic counseling and testing for common hereditary breast cancer syndromes: a paper from the 2007 William Beaumont hospital symposium on molecular pathology.
Allain DC
J Mol Diagn; 2008 Sep; 10(5):383-95. PubMed ID: 18687797
[TBL] [Abstract][Full Text] [Related]
5. BRCA screening.
Med Lett Drugs Ther; 2007 Nov; 49(1274):93-4. PubMed ID: 18007543
[No Abstract] [Full Text] [Related]
6. BRCA1 and BRCA2 mutations in breast and ovarian cancer syndrome: reflection on the Creighton University historical series of high risk families.
Sinilnikova OM; Mazoyer S; Bonnardel C; Lynch HT; Narod SA; Lenoir GM
Fam Cancer; 2006; 5(1):15-20. PubMed ID: 16528604
[TBL] [Abstract][Full Text] [Related]
7. USPSTF Recommendations for BRCA1 and BRCA2 Testing in the Context of a Transformative National Cancer Control Plan.
Rajagopal PS; Nielsen S; Olopade OI
JAMA Netw Open; 2019 Aug; 2(8):e1910142. PubMed ID: 31434110
[No Abstract] [Full Text] [Related]
8. Further development and evaluation of a breast/ovarian cancer genetics referral screening tool.
Bellcross C
Genet Med; 2010 Apr; 12(4):240. PubMed ID: 20395744
[No Abstract] [Full Text] [Related]
9. Management updates for women with a BRCA1 or BRCA2 mutation.
Nusbaum R; Isaacs C
Mol Diagn Ther; 2007; 11(3):133-44. PubMed ID: 17570734
[TBL] [Abstract][Full Text] [Related]
10. A Cost-Effectiveness Evaluation of Germline BRCA1 and BRCA2 Testing in UK Women with Ovarian Cancer.
Eccleston A; Bentley A; Dyer M; Strydom A; Vereecken W; George A; Rahman N
Value Health; 2017 Apr; 20(4):567-576. PubMed ID: 28407998
[TBL] [Abstract][Full Text] [Related]
11. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
Satagopan JM; Boyd J; Kauff ND; Robson M; Scheuer L; Narod S; Offit K
Clin Cancer Res; 2002 Dec; 8(12):3776-81. PubMed ID: 12473589
[TBL] [Abstract][Full Text] [Related]
12. [What attitude to women at high risk of breast cancer?].
Livon D; Moretta J; Noguès C
Presse Med; 2019 Oct; 48(10):1092-1100. PubMed ID: 31706893
[TBL] [Abstract][Full Text] [Related]
13. Hereditary breast and ovarian cancers.
Herman LM;
JAAPA; 2008 May; 21(5):18, 21. PubMed ID: 18556884
[No Abstract] [Full Text] [Related]
14. Genetic testing for hereditary breast and ovarian cancer and the USPSTF recommendations.
Wood ME; Garber JE; Isaacs C; Masood S; Bedrosian I; Tung N; Chun J; Schnabel FR; Arun BK;
Breast J; 2019 Jul; 25(4):575-577. PubMed ID: 31280501
[No Abstract] [Full Text] [Related]
15. [Familial breast cancer, ovarian cancer].
Inoue M
Nihon Rinsho; 2006 Jun; Suppl 2():366-70. PubMed ID: 16817423
[No Abstract] [Full Text] [Related]
16. Germline BRCA testing is moving from cancer risk assessment to a predictive biomarker for targeting cancer therapeutics.
Moreno L; Linossi C; Esteban I; Gadea N; Carrasco E; Bonache S; Gutiérrez-Enríquez S; Cruz C; Díez O; Balmaña J
Clin Transl Oncol; 2016 Oct; 18(10):981-7. PubMed ID: 26742938
[TBL] [Abstract][Full Text] [Related]
17. [Genetic testing in patients at risk for carcinoma of the breast].
Kiechle M
Dtsch Med Wochenschr; 2006 Oct; 131(43):2420-2. PubMed ID: 17054060
[No Abstract] [Full Text] [Related]
18. Hereditary breast cancer and genetic counseling in young women.
Brunet J
Breast Cancer Res Treat; 2010 Sep; 123 Suppl 1():7-9. PubMed ID: 20711663
[No Abstract] [Full Text] [Related]
19. Introduction to epidemiology of breast and ovarian cancers.
Adaniel C; Kirchhoff T
Ann Oncol; 2013 Nov; 24 Suppl 8():viii61-viii62. PubMed ID: 24131972
[No Abstract] [Full Text] [Related]
20. Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families.
Giannini G; Capalbo C; Ristori E; Ricevuto E; Sidoni T; Buffone A; Cortesi E; Marchetti P; Scambia G; Tomao S; Rinaldi C; Zani M; Ferraro S; Frati L; Screpanti I; Gulino A
Breast Cancer Res Treat; 2006 Nov; 100(1):83-91. PubMed ID: 16847550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]